Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 437

1.

Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome.

Prall WC, Czibere A, Grall F, Spentzos D, Steidl U, Giagounidis AA, Kuendgen A, Otu H, Rong A, Libermann TA, Germing U, Gattermann N, Haas R, Aivado M.

Int J Hematol. 2009 Mar;89(2):173-87. doi: 10.1007/s12185-008-0242-9.

PMID:
19152102
2.

Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.

Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP.

Blood. 2002 Nov 15;100(10):3553-60.

3.

Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome.

Vasikova A, Budinska E, Belickova M, Cermak J, Bruchova H.

Neoplasma. 2009;56(4):335-42.

PMID:
19469654
4.
5.

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, Sloand EM, Young NS.

Blood. 2004 Dec 15;104(13):4210-8.

6.
7.

[Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].

Qian J, Chen ZX, Wang W, Cen JN, Xue YQ.

Zhonghua Yi Xue Za Zhi. 2004 Aug 2;84(15):1260-4. Chinese.

PMID:
15387962
8.

Expression of Rap1GAP in human myeloid disease following microarray selection.

Qi X, Chen Z, Qian J, Cen J, Gu M.

Genet Mol Res. 2008 Apr 29;7(2):379-87.

9.

Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.

Qian J, Chen Z, Wang W, Cen J, Xue Y.

Oncol Rep. 2005 Nov;14(5):1189-97.

PMID:
16211284
10.

Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.

Maratheftis CI, Andreakos E, Moutsopoulos HM, Voulgarelis M.

Clin Cancer Res. 2007 Feb 15;13(4):1154-60.

11.

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

Sternberg A, Killick S, Littlewood T, Hatton C, Peniket A, Seidl T, Soneji S, Leach J, Bowen D, Chapman C, Standen G, Massey E, Robinson L, Vadher B, Kaczmarski R, Janmohammed R, Clipsham K, Carr A, Vyas P.

Blood. 2005 Nov 1;106(9):2982-91.

12.

Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.

Gueller S, Komor M, Nowak D, Baldus CD, de Vos S, Hoelzer D, Ottmann OG, Hofmann WK.

Exp Hematol. 2010 Sep;38(9):718-32, 732.e1-6. doi: 10.1016/j.exphem.2010.04.018.

PMID:
20621626
13.

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.

Pellagatti A, Benner A, Mills KI, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jädersten M, Verma A, McDonald EJ, Killick S, Hellström-Lindberg E, Bullinger L, Wainscoat JS, Boultwood J.

J Clin Oncol. 2013 Oct 1;31(28):3557-64. doi: 10.1200/JCO.2012.45.5626.

PMID:
24002510
14.

The lower risk MDS patient at risk of rapid progression.

Mittelman M, Oster HS, Hoffman M, Neumann D.

Leuk Res. 2010 Dec;34(12):1551-5. doi: 10.1016/j.leukres.2010.05.023. Review.

PMID:
20573398
15.

Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).

Economopoulou C, Pappa V, Papageorgiou S, Kontsioti F, Economopoulou P, Charitidou E, Girkas K, Kapsimali V, Papasteriadi C, Tsirigotis P, Papageorgiou E, Dervenoulas J, Economopoulos T.

Ann Hematol. 2010 Apr;89(4):349-58. doi: 10.1007/s00277-009-0835-2.

PMID:
19813013
16.

CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.

Heinrichs S, Berman JN, Ortiz TM, Kornblau SM, Neuberg DS, Estey EH, Look AT.

Br J Haematol. 2005 Jul;130(1):83-6.

PMID:
15982348
17.

Gene expression in CD34(+) cells from normal bone marrow and leukemic origins.

Gu J, Zhang QH, Huang QH, Ren SX, Wu XY, Ye M, Huang CH, Fu G, Zhou J, Niu C, Han ZG, Chen SJ, Chen Z.

Hematol J. 2000;1(3):206-17.

PMID:
11920191
18.

Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.

Qi H, Xiao L, Lingyun W, Ying T, Yi-Zhi L, Shao-Xu Y, Quan P.

Ann Hematol. 2006 Feb;85(2):95-101.

PMID:
16328478
19.
20.

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S, Campbell LJ, Wang L, Langford CF, Fidler C, Oscier D, Aul C, Wainscoat JS, Boultwood J.

Blood. 2006 Jul 1;108(1):337-45. Erratum in: Blood. 2006 Aug 15;108(4):1128.

Items per page

Supplemental Content

Support Center